Following the 2022 Fall Clinical Dermatology meeting, Zoe Diana Draelos, MD; Mark G. Lebwohl, MD; Peter A. Lio, MD; and Elizabeth Swanson, MD, and engage in a rapid-fire question-and-answer sessions, hosted by Dermatology Times. Topics include most surprising new data, what needs follow-up, and the biggest winner out of the meeting.
Nada Elbuluk, MD, and David Rosmarin, MD, discuss screening patients with vitiligo for common comorbidities.
Nada Elbuluk, MD, and David Rosmarin, MD, provide an overview of vitiligo, its prevalence, and potential triggers.
Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, explore the impact of recent advances in atopic dermatitis treatment and look to future possibilities.
Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, review the challenges of identifying the right regimens for patients and the many factors that influence treatment selection.
Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, discuss how to talk about safety concerns with patients.
The author of a new study on JAK inhibitors discusses his surprising findings on the safety profiles of these new medications for dermatologic conditions.
Mark G. Lebwohl, MD, and Alice B. Gottlieb, MD, PhD, discuss gaps in care for the treatment of plaque psoriasis.
Expert dermatologists discuss the methods of a study of US health records of patients with generalized pustular psoriasis.
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, provide an overview of generalized pustular psoriasis, identifying flares, the burden on patients, and available treatment options.